Next Generation News and Research

RSS

Presbyterian Hospital collaborates with New York Center for Autism to establish Institute for Brain Development

NewYork-Presbyterian Hospital, along with its affiliated medical schools Columbia University College of Physicians and Surgeons and Weill Cornell Medical College, announced its collaboration with the New York Center for Autism to establish the Institute for Brain Development, a comprehensive, state-of-the-art institute dedicated to addressing the pressing clinical needs of individuals living with autism spectrum disorders and other developmental disorders of the brain, across their lifespan.

8 Oct 2010

Hard combat can devastate veterans until old age

The trauma from hard combat can devastate veterans until old age, even as it influences others to be wiser, gentler and more accepting in their twilight years, a new University of Florida study finds.

8 Oct 2010

AnalizaDx SIA technology, Nanosphere Verisens assay effective for prostate cancer diagnosis

At the annual meeting of the North-Central American Urological Association, Mark Stovsky, MD, Case Western Reserve University School of Medicine Case Medical Center, and principal investigator, presented positive data combining the AnalizaDx SIA technology with the Nanosphere Verisens ultra-sensitive PSA assay.

7 Oct 2010

Viking Systems launches Next Generation 3DHD Visualization System

Viking Systems, Inc. reported today that it officially launched its Next Generation 3DHD Visualization System on October 4, 2010 at the American College of Surgeons Clinical Congress (ACS) held October 3-7 in Washington, DC. The Company also announced today its first distribution partners for the new system.

7 Oct 2010

UEM, San Diego School of Medicine enter partnership to address medical human resource needs in Mozambique

Aimed at enhancing the capacity of Mozambique's flagship medical school, Universidade Eduardo Modlane (UEM), in pre- and postgraduate medical education, the University of California, San Diego School of Medicine and UEM entered into a partnership in 2007 to address both short and long-term medical human resource needs in Mozambique.

7 Oct 2010

Synthetic Genomics, JCVI announce formation of new company to develop next generation vaccines

The company Synthetic Genomics Inc. (SGI) and the not-for-profit research organization, the J. Craig Venter Institute (JCVI) today announced the formation of a new company, Synthetic Genomics Vaccines Inc. (SGVI).

7 Oct 2010

SOKO signs revenue-sharing agreement with Bin Xian for education offering

SOKO Fitness & Spa Group, Inc., an operator of fitness centers, beauty salons and spas in Northeast China as well as suburban Beijing, today announced that it has signed a cooperation and revenue-sharing agreement with Bin Xian Vocational Technology and Education Center ("Bin Xian"), which is located in suburban Harbin, China.

6 Oct 2010

UCLA-led consortium receives $9.9M to compare wireless and telephone management after hospitalizations

A UCLA-led consortium of five University of California medical schools, plus Cedars-Sinai Medical Center in Los Angeles, has received $9.9 million from the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality to research the use of wireless and telephone care management to reduce hospital readmissions for heart failure patients.

6 Oct 2010

Accuray receives SBIR grant to develop high-energy X-ray source for Homeland Security applications

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the company was awarded a $1 million Small Business Innovation Research (SBIR) grant by the U.S. Government to be used toward further development of a high-energy X-ray source for Homeland Security applications.

6 Oct 2010

FDA grants orphan drug designation to hGH-CTP for treating growth hormone deficiency

PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency.

5 Oct 2010

NIH awards contract to develop nanotechnology tools for atherosclerosis treatment

Georgia Tech and Emory University have received a five-year $14.6 million contract from the National Institutes of Health (NIH) to continue the development of nanotechnology and biomolecular engineering tools and methodologies for detecting and treating atherosclerosis.

5 Oct 2010

HHS announces $473 million grant to help people make effective healthcare decisions

HHS' Agency for Healthcare Research and Quality today announced the award of $473 million in grants and contracts to support projects that will help people make health care decisions based on the best evidence of effectiveness. The funding announced today covers all of AHRQ's allocation and $173 million administered for the HHS Secretary by AHRQ.

1 Oct 2010

Agilent introduces SureSelect Kinome Target Enrichment Kit to focus next-generation sequencing studies

Agilent Technologies Inc. today introduced the SureSelect Kinome Target Enrichment Kit, enabling researchers to focus next generation sequencing studies on expressed kinases (the kinome). Researchers increasingly are looking at human kinases as a rich, proven source of biomarkers as well as potential drug targets for cancers and other diseases.

30 Sep 2010

Penn Medicine selected as study site for PPMI

The Penn Medicine Parkinson's Disease and Movement Disorders Center announced that it is one of 18 official study sites for the Parkinson's Progression Markers Initiative (PPMI), a landmark observational clinical study sponsored by The Michael J. Fox Foundation, which will use a combination of advanced imaging, biologics sampling and behavioral assessments to identify biomarkers of Parkinson's disease progression.

30 Sep 2010

New $1.76M study seeks to identify novel methods of diagnosing osteoporosis

A $1.76 million study at Rensselaer Polytechnic Institute seeks to identify new methods of diagnosing osteoporosis and inform the development of next-generation drugs to treat the bone disease.

30 Sep 2010

FDA clears Abbott's RevitaLens Ocutec contact lens disinfecting solution

Abbott has received U.S. Food and Drug Administration (FDA) market clearance for RevitaLens Ocutec™, a unique next-generation multi-purpose disinfecting solution for silicone hydrogel and conventional soft contact lenses.

30 Sep 2010

NeurAxon closes convertible debenture financing

NeurAxon, Inc., a development-stage pharmaceutical company that is designing and developing next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced that it has closed a convertible debenture financing in which the convertible debentures are convertible under specified circumstances into existing class B preferred shares for a total of approximately $14 million.

29 Sep 2010

IN.PACT drug-eluting balloons show promising results for superficial femoral artery disease treatment

Advancing research on drug-eluting balloons for the treatment of coronary and peripheral artery disease, Medtronic, Inc., today announced the latest results from the IN.PACT drug-eluting balloon (DEB) clinical program presented last week at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference.

29 Sep 2010

Omicsoft's Next Generation Sequencing tools integrated with GeneGo's MetaCore data mining suite

GeneGo, Inc., the leading systems biology tools company and Omicsoft Corporation, the leader in the OMIC repository and analysis field, announced today integration of Omicsoft's Next Generation Sequencing tools with GeneGo's MetaCore data mining suite.

29 Sep 2010

New topical microbicide gel can prevent HIV transmission

Amyloid protein structures are best known for the troubles they pose in the brains of Alzheimer's patients. Now researchers are trying to exploit their presence in a very different place in semen to find a new way to stop HIV.

29 Sep 2010

Next Generation News and Research

Presbyterian Hospital collaborates with New York Center for Autism to establish Institute for Brain Development

Hard combat can devastate veterans until old age

AnalizaDx SIA technology, Nanosphere Verisens assay effective for prostate cancer diagnosis

Viking Systems launches Next Generation 3DHD Visualization System

UEM, San Diego School of Medicine enter partnership to address medical human resource needs in Mozambique

Synthetic Genomics, JCVI announce formation of new company to develop next generation vaccines

SOKO signs revenue-sharing agreement with Bin Xian for education offering

UCLA-led consortium receives $9.9M to compare wireless and telephone management after hospitalizations

Accuray receives SBIR grant to develop high-energy X-ray source for Homeland Security applications

FDA grants orphan drug designation to hGH-CTP for treating growth hormone deficiency

NIH awards contract to develop nanotechnology tools for atherosclerosis treatment

HHS announces $473 million grant to help people make effective healthcare decisions

Agilent introduces SureSelect Kinome Target Enrichment Kit to focus next-generation sequencing studies

Penn Medicine selected as study site for PPMI

New $1.76M study seeks to identify novel methods of diagnosing osteoporosis

FDA clears Abbott's RevitaLens Ocutec contact lens disinfecting solution

NeurAxon closes convertible debenture financing

IN.PACT drug-eluting balloons show promising results for superficial femoral artery disease treatment

Omicsoft's Next Generation Sequencing tools integrated with GeneGo's MetaCore data mining suite

New topical microbicide gel can prevent HIV transmission

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News